- Open
- 5.80
- High
- 6.10
- Low
- 5.60
- Close
- 6.10
- Change
- +0.10 (1.72%)
- Volume
- 2,485,415
| 22 Oct 2026 | 07:00:03 | US Kidney Care National Plan |
| 19 Oct 2026 | 13:15:46 | Holding(s) in Company |
| 5 Oct 2026 | 10:25:52 | Holding(s) in Company |
| 2 Oct 2026 | 16:06:43 | Director/PDMR Shareholding (Replacement) |
| 7 Jan 2025 | Annual Report and Accounts (to 2024-06-30) | |
| 16 Jan 2024 | Annual Report and Accounts (to 2023-06-30) | |
| 30 Dec 2022 | Annual Report and Accounts (to 2022-06-30) |
Renalytix PLC develops artificial intelligence-enabled clinical diagnostic solutions specifically for kidney disease. The company's primary product, kidneyintelX.dkd, aims to enhance patient outcomes through improved clinical management of kidney conditions. Renalytix operates in the healthcare sector, targeting healthcare providers and laboratories, primarily in the United States and Ireland, with a focus on expanding its commercial testing capabilities and reimbursement policies.
| 22 Oct 2026 | 07:00:03 | US Kidney Care National Plan |
| 19 Oct 2026 | 13:15:46 | Holding(s) in Company |
| 5 Oct 2026 | 10:25:52 | Holding(s) in Company |
| 2 Oct 2026 | 16:06:43 | Director/PDMR Shareholding (Replacement) |
| 7 Jan 2025 | Annual Report and Accounts (to 2024-06-30) | |
| 16 Jan 2024 | Annual Report and Accounts (to 2023-06-30) | |
| 30 Dec 2022 | Annual Report and Accounts (to 2022-06-30) |
Renalytix PLC develops artificial intelligence-enabled clinical diagnostic solutions specifically for kidney disease. The company's primary product, kidneyintelX.dkd, aims to enhance patient outcomes through improved clinical management of kidney conditions. Renalytix operates in the healthcare sector, targeting healthcare providers and laboratories, primarily in the United States and Ireland, with a focus on expanding its commercial testing capabilities and reimbursement policies.
| 2 Oct 2026 |
| 15:56:21 |
| Holding(s) in Company |
| 11 Sept 2026 |
| AIM movers: LPA upgrade and Renalytix boss buys shares |
| 8 Sept 2026 | AIM movers: 80 Mile proposes merger and Renalytix returns from suspension after fundraising |
| 26 Mar 2026 | Renalytix first half revenues rise, but cautions pipeline is taking longer to convert |
| 2 Oct 2026 |
| 15:56:21 |
| Holding(s) in Company |
| 11 Sept 2026 |
| AIM movers: LPA upgrade and Renalytix boss buys shares |
| 8 Sept 2026 | AIM movers: 80 Mile proposes merger and Renalytix returns from suspension after fundraising |
| 26 Mar 2026 | Renalytix first half revenues rise, but cautions pipeline is taking longer to convert |
| Issuer | Mkt cap | 1Y |
|---|---|---|
| £377m | -0.5% | |
| £271m | -0.0% | |
RENXRenalytix PLC | £41m | -0.3% |
| £28m | -0.1% | |
| £17m | +1.2% | |
| £9m | -0.7% |
| Issuer | Mkt cap | 1Y |
|---|---|---|
| £377m | -0.5% | |
| £271m | -0.0% | |
RENXRenalytix PLC | £41m | -0.3% |
| £28m | -0.1% | |
| £17m | +1.2% | |
| £9m | -0.7% |